Tang Jang Wang

Title: Innovative Contributions of Tang Jang Wang in Prostate Cancer Detection

Introduction

Tang Jang Wang, a notable inventor based in Poway, CA, holds six patents that demonstrate her significant contributions to medical diagnostics, particularly in the field of prostate cancer. Through her work, she has paved the way for innovative methods to detect and manage this prevalent health issue.

Latest Patents

Among her notable patents, the first focuses on "Forms of prostate specific antigens and methods for their detection." This patent identifies inactive precursor forms of prostate specific antigen (pPSA) that exist in the serum and tissues of prostate cancer patients. It provides antibodies specific to pPSA and outlines methods for detecting these inactive precursors in human physiological fluids and tissues, alongside developing diagnostic kits useful in the diagnosis and management of prostate cancer.

Another significant patent by Wang is centered around "Methods and device for detecting prostate specific antigen (PSA)." This invention includes an immunoassay device designed to detect antigens, such as PSA, in biological samples. The device features a solid support containing multiple reaction zones with capture antibodies directed at the antigen. The method involves exposing a test sample to a mixture of incubation antibodies in varying concentrations before interacting with the capture antibodies, allowing the determination of a range of antigen concentrations.

Career Highlights

Throughout her career, Tang Jang Wang has demonstrated a commitment to advancing detection methodologies in the healthcare sector. Her innovative work has significant implications for improving early diagnosis and treatment outcomes for prostate cancer patients. She has worked for prominent companies, including Hybritech Incorporated, where her contributions have been integral to the development of diagnostic technologies.

Collaborations

Wang has collaborated with various professionals in her field, including esteemed colleagues like Stephen D. Mikolajczyk and Harry G. Rittenhouse. These collaborations have enhanced her research and allowed for the pooling of resources and knowledge that drives innovation in medical diagnostics.

Conclusion

In summary, Tang Jang Wang’s inventive spirit and dedication to improving prostate cancer detection underscore her status as a leading inventor in her field. Her patents not only reflect her expertise but also signify her lasting impact on the development of diagnostic technologies that contribute meaningfully to patient care and medical advancements.